MIV Therapeutics Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MIV Therapeutics Inc.
Growth by innovation is almost considered a birthright in interventional cardiology, and based on presentations at this year's Transcatheter Cardiovascular Therapeutics meeting, held this September in San Francisco, it seems clear that innovation still reigns supreme in this specialty. However, as in other medical device markets, ongoing economic and regulatory pressures are taking their toll, particularly in the drug-eluting stent market, as the field adjusts to a new era of cost control and economic uncertainty.
In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Summary of recent device mergers and acquisitions, alliances, and financings.
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Other Names / Subsidiaries
- MIVI Technologies
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.